Xenon Pharmaceuticals Announces Positive Topline Results from Ph

XENE: Xenon Pharmaceuticals Inc.
2021-10-04 07:00:00
Xenon Pharmaceuticals Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101 for the Treatment of Focal Epilepsy